Liver transplantation for intestinal malignancies
Digestive and Liver Disease · 2025
DOI: 10.1016/j.dld.2025.08.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Alessandro Vitale und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical, Oncological, and Gastroenterological Sciences, Padua University, Padova, Italy. Electronic address: alessandro.vitale@unipd.i…. Hauptthemen laut MEDLINE: Liver Transplantation, Patient Selection, Liver Neoplasms, Intestinal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Liver transplantation (LT) is increasingly recognised as a valuable treatment option in carefully selected cases of metastatic intestinal cancers. While traditionally reserved for primary liver tumours such as hepatocellular carcinoma (HCC), recent evidence has broadened the transplant oncology paradigm to include colorectal liver metastases (CRLM) and neuroendocrine liver metastases (NELM). This review explores the evolving indications, patient selection criteria, and clinical outcomes of LT in these contexts, emphasising the need for a conceptual and methodological reassessment. We distinguish between prognostic factors, which are variables independently linked with clinical outcomes, and selection criteria, which determine patient eligibility and transplant prioritisation. This distinction is vital for proper candidate stratification. It emphasises the importance of using overall survival as the primary endpoint in transplant oncology rather than recurrence-free survival, which can be misleading due to early detection bias and competing risks. The idea of "transplant benefit," defined as the survival gain attributable to LT compared to non-transplant strategies, is proposed as a fair and informative measure for ethical allocation. Data from prospective studies, such as SECA I-II and the TransMet trial, offer estimates of benefit in different indications, showing significant variation, from 22.5 months in per-protocol CRLM to around 12 months in NELM. We also examine intention-to-treat versus per-protocol analyses, the impact of dropout and waiting list mortality, and the implications for allocation policy. Finally, we outline future directions, including expansion to unresectable tumours beyond the criteria and borderline resectable tumours within the criteria. In the era of personalised medicine, LT for intestinal malignancies requires careful patient selection, transplant ethics, and collaborative oncologic governance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical, Oncological, and Gastroenterological Sciences, Padua University, Padova, Italy. Electronic address: alessandro.vitale@unipd.it.
- Medstar Georgetown Transplantation Institute, Medstar Georgetown University Hospital. 3800 Reservoir Road, WA DC 20016, USA.
- Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum Tübingen, Tübingen, Germany.
- Department of Surgical, Oncological, and Gastroenterological Sciences, Padua University, Padova, Italy.
- Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy. Electronic address: egiannini@unige.it.
- Department of Precision and Regenerative Medicine and Ionian Area, Hepatobiliary Surgery and Liver Transplant Unit, University of Bari Aldo Moro, Bari, Italy.
Zitieren
APA
Vitale, A., Gondolesi, G., Finotti, M., De Nardi, C., Naldini, C., Giannini, E. G., & D'Amico, F. (2025). Liver transplantation for intestinal malignancies. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2025.08.008
Vancouver
Vitale A, Gondolesi G, Finotti M, De Nardi C, Naldini C, Giannini EG, et al. Liver transplantation for intestinal malignancies. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2025.08.008
BibTeX
@article{Vitale2025,
author = {Vitale, Alessandro and Gondolesi, Gabriel and Finotti, Michele and De Nardi, Clarissa and Naldini, Chiara and Giannini, Edoardo G and D'Amico, Francesco},
title = {Liver transplantation for intestinal malignancies},
journal = {Digestive and Liver Disease},
year = {2025},
doi = {10.1016/j.dld.2025.08.008}
}
EUVIMED